sorafenib has been researched along with plx7904 in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (plx7904) | Trials (plx7904) | Recent Studies (post-2010) (plx7904) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 6 | 0 | 6 |
| Protein | Taxonomy | sorafenib (IC50) | plx7904 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase B-raf | Homo sapiens (human) | 0.0101 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agianian, B; Gavathiotis, E | 1 |
1 review(s) available for sorafenib and plx7904
| Article | Year |
|---|---|
Current Insights of BRAF Inhibitors in Cancer.
Topics: Animals; Drug Discovery; Humans; Mutation; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf | 2018 |